Michael Wang

3 ta ish

The University of Texas MD Anderson Cancer Center

1. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

   Enli Liu, David Marín, Pinaki P. Banerjee +24

   Maqola20207 iqtibos

   ABIABI:AkademIndex/2026.other.312682

2. Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma

   Larysa Sanchez, Yucai Wang, David S. Siegel +1

   Sharh maqolaOAOchiq kirish20162 iqtibos

   ABIABI:AkademIndex/2026.other.082809

3. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

   Jeremy S Abramson, M. Lia Palomba, Leo I. Gordon +19

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.296869